| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Cyclooxygenase inhibition and thrombogenicity
|
Catella-Lawson, Francesca
|
|
2001
|
110 |
3S1 |
p. 28-32
5 p.
|
artikel
|
| 2 |
Efficacy of cyclooxygenase-2–specific inhibitors
|
Cannon, Grant W
|
|
2001
|
110 |
3S1 |
p. 6-12
7 p.
|
artikel
|
| 3 |
Epidemiologic assessment of the safety of conventional nonsteroidal anti-inflammatory drugs
|
Hernández-Dı́az, Sonia
|
|
2001
|
110 |
3S1 |
p. 20-27
8 p.
|
artikel
|
| 4 |
Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2–specific inhibitors
|
Buttgereit, Frank
|
|
2001
|
110 |
3S1 |
p. 13-19
7 p.
|
artikel
|
| 5 |
Introduction
|
Lipsky, Peter E.
|
|
2001
|
110 |
3S1 |
p. 1-2
2 p.
|
artikel
|
| 6 |
Potential impact of selective cyclooxygenase-2 inhibitors on bone metabolism in health and disease
|
Raisz, Lawrence G
|
|
2001
|
110 |
3S1 |
p. 43-45
3 p.
|
artikel
|
| 7 |
Recommendations for the clinical use of cyclooxygenase-2–specific inhibitors
|
Lipsky, Peter E.
|
|
2001
|
110 |
3S1 |
p. 3-5
3 p.
|
artikel
|
| 8 |
Renal aspects of treatment with conventional nonsteroidal anti-inflammatory drugs versus cyclooxygenase-2–specific inhibitors
|
Whelton, Andrew
|
|
2001
|
110 |
3S1 |
p. 33-42
10 p.
|
artikel
|
| 9 |
The economic implications of cyclooxygenase-2–specific inhibitors
|
Peloso, Paul M
|
|
2001
|
110 |
3S1 |
p. 50-54
5 p.
|
artikel
|
| 10 |
The role of acetaminophen in the management of patients with osteoarthritis
|
Shamoon, Mohammed
|
|
2001
|
110 |
3S1 |
p. 46-49
4 p.
|
artikel
|
Tijdschrift beschrijving